Modified exhaled nitric oxide measurement in monocrotaline-exposed rats to monitor pulmonary hypertension

M. S. Strobl, C. Schreiber, S. Hubmer, H. Bergmeister, I. M. Lang, D. Bonderman (Austria)

Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Session: Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Session type: Thematic Poster Session
Number: 3902
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. S. Strobl, C. Schreiber, S. Hubmer, H. Bergmeister, I. M. Lang, D. Bonderman (Austria). Modified exhaled nitric oxide measurement in monocrotaline-exposed rats to monitor pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 3902

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Fractional exhaled nitric oxide in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Exhaled nitric oxide levels in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016


Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 584s
Year: 2003

Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 55s
Year: 2007

Endothelin system, exhaled nitric oxide and high altitude pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 551s
Year: 2007

Exhaled nitric oxide and pulmonary function tests in children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 759s
Year: 2007

Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
Source: Eur Respir J 2003; 21: 433-438
Year: 2003



An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004



Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model
Source: Eur Respir J 2006; 28: 1236-1244
Year: 2006



Infused nitric oxide in experimental pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 348s
Year: 2007

Measurement of exhaled nitric oxide in children
Source: Guideline 2002
Year: 2002

Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Diagnosing asthma using exhaled nitric oxide (eNO) measurements
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003


Effect of caffeine on exhaled nitric oxide measurements in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003

Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Pulmonary function test and fraction of exhaled nitric oxide of asthma in remission
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010


Nitric oxide metabolite flux during exercise in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011

Exhaled nitric oxide measurement in the diagnosis and management of pulmonary tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009


Increased eNO and pulmonary iNOS expression in eNOS null mice
Source: Eur Respir J 2003; 21: 770-773
Year: 2003